Hypertension in Renal Transplant Patients: A Prospective Descriptive and Analytical Study

Ghattas Mohamed Amine *

Nephrology, Dialysis and Renal Transplantation Unit, University Hospital Ibn Rochd, Casablanca, Morocco.

Kharrat Assia

Nephrology, Dialysis and Renal Transplantation Unit, University Hospital Ibn Rochd, Casablanca, Morocco.

Medkouri Ghislaine

Nephrology, Dialysis and Renal Transplantation Unit, University Hospital Ibn Rochd, Casablanca, Morocco.

Naoufal Mtioui

Nephrology, Dialysis and Renal Transplantation Unit, University Hospital Ibn Rochd, Casablanca, Morocco.

Selma Elkhayat

Nephrology, Dialysis and Renal Transplantation Unit, University Hospital Ibn Rochd, Casablanca, Morocco.

Mohamed Ali Zamd

Nephrology, Dialysis and Renal Transplantation Unit, University Hospital Ibn Rochd, Casablanca, Morocco.

Mohamed Benghanem Gharbi

Nephrology, Dialysis and Renal Transplantation Unit, University Hospital Ibn Rochd, Casablanca, Morocco.

*Author to whom correspondence should be addressed.


Abstract

The prevalence of hypertension in kidney transplant patients is significant. The physiological circadian evolution of blood pressure (BP) shows a nocturnal decrease of 10 to 20%, called dipping rate. According to this dipping rate, several profiles have been determined, some of which were correlated with the occurrence of cardiovascular events. We set two main objectives for this study: to evaluate the prevalence of hypertension in kidney transplant patients and to determine the dipping rate of hypertensive transplant patients in our series, and its impact on albuminuria. 62 renal transplant patients were included in this study. They underwent 24-hour ambulatory blood pressure measurement (ABPM) with the Suntech AccuWin Pro device in a nephrology department. Arterial hypertension (AH) and dipper status were defined according to the 2018 European Society of Cardiology (ESC) recommendations. A Mann Whitney test assessed the impact of dipper status on albuminuria. The prevalence of hypertension was 52% in a population with a median age of 44 years; 67% of patients had albuminuria >30 mg/24 hours. 3% of hypertensive patients were dippers, 42% of patients were nondippers, and 6% of patients were reverse dippers. A correlation between albuminuria and reverse dipper profile was found with a p = 0.044. In renal transplant recipients, arterial hypertension is a major risk factor of graft loss.  Blood pressure control in our population is suboptimal, especially in a population where the impact of nocturnal hypertension on markers of renal damage is well documented.

Keywords: Hypertension, kidney transplant, ambulatory blood pressure measurement, albuminuria


How to Cite

Amine, G. M., Assia , K., Ghislaine , M., Mtioui , N., Elkhayat , S., Zamd , M. A., & Gharbi, M. B. (2024). Hypertension in Renal Transplant Patients: A Prospective Descriptive and Analytical Study. Asian Journal of Research in Nephrology, 7(1), 39–44. Retrieved from https://journalajrn.com/index.php/AJRN/article/view/74

Downloads

Download data is not yet available.

References

Sarafidis PA, Li S, Chen SC, Collins AJ, Brown WW, Klag MJ et al. Hypertension awareness, treatment, and control in chronic kidney disease. Am J Med. Avr. 2008;121(4):332‑40.

Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C et al. 201 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American college of Cardiology/American heart association task force on clinical practice guidelines. Hypertens Dallas Tex 1979. Juin. 2018;71(6):1269‑324.

Hypertension in dialysis patients: A consensus document by the European renal and cardiovascular medicine (EURECA-m) working group of the European renal association - European dialysis and transplant association (ERA-EDTA) and the hypertension and the kidney working group of the European Society of Hypertension (ESH); 2017.

Hypertension in chronic kidney disease part 2: Role of ambulatory and home blood pressure monitoring for assessing alterations in blood pressure variability and blood pressure profiles; 2016.

Parati G, Ochoa JE, Bilo G, Agarwal R, Covic A, Dekker FW et al. Hypertension in chronic kidney disease part 1: Out-of-office blood pressure monitoring: Methods, thresholds, and patterns. Hypertens Dallas Tex 1979. Juin. 2016;67(6):1093‑101.

Sarafidis PA, Loutradis C, Karpetas A, Tzanis G, Bikos A, Raptis V et al. The association of interdialytic blood pressure variability with cardiovascular events and all-cause mortality in haemodialysis patients. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 1 mars. 2019;34(3):515‑23.

Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S et al. Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 1 mai. 2019;34(5):760‑73.

Pilmore H, Dent H, Chang S, McDonald SP, Chadban SJ. Reduction in cardiovascular death after kidney transplantation. Transplantation. 15 avr. 2010;89(7):851‑7.

Kidney Disease: Improving Global Outcomes (KDIGO) blood pressure work group. KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. mars. 2021;99(3S):S1‑87.

Halimi JM, Ortiz A, Sarafidis PA, Mallamaci F, Wuerzner G, Pisano A et al. Hypertension in kidney transplantation: A consensus statement of the « hypertension and the kidney » working group of the European Society of Hypertension. J Hypertens. 1 août. 2021;39(8):1513‑21.

ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal. Oxford Academic; 2018.

Opelz G, Döhler B. Improved long‐term outcomes after renal transplantation associated with blood pressure control. Am J Transplant. 2005, 1 nov;5(11):2725‑31.

Fernández-Vega F, Tejada F, Baltar J, Laures A, Gómez E, Alvarez J. Ambulatory blood pressure after renal transplantation. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2001;16 Suppl 1:110‑3.

Lingens N, Dobos E, Witte K, Busch C, Lemmer B, Klaus G et al. Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol Berl Ger. Févr. 1997;11(1):23‑6.

Ahmed J, Ozorio V, Farrant M, Van Der Merwe W. Ambulatory vs office blood pressure monitoring in renal transplant recipients. J Clin Hypertens. 2015;17(1): 46‑50.

Kooman JP, Christiaans MH, Boots JM, van Der Sande FM, Leunissen KM, van Hooff JP. A comparison between office and ambulatory blood pressure measurements in renal transplant patients with chronic transplant nephropathy. Am J Kidney Dis Off J Natl Kidney Found. Juin. 2001;37(6):1170‑6.

Kanno A, Kikuya M, Asayama K, Satoh M, Inoue R, Hosaka M et al. Night-time blood pressure is associated with the development of chronic kidney disease in a general population: The ohasama study. J Hypertens. 2013, dec;31(12):2410.

Cha RH, Kim S, Ae Yoon S, Ryu DR, Eun Oh J, Han SY et al. Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: Results of the APrODiTe study. Hypertens Res Off J Jpn Soc Hypertens. Févr. 2014;37(2):172‑8.

Wing LMH, Chowdhury EK, Reid CM, Beilin LJ, Brown MA, ANBP2 Management Committee. Night-time ambulatory blood pressure is the best pretreatment blood pressure predictor of 11-year mortality in treated older hypertensives. Blood Press Monit. 2018, oct;23(5):237‑43.